LobbyingAmerican Association for Cancer Research lobbying by quarter
American Association for Cancer Research's latest lobbying report covers Q2 2026, at $100K. The four quarters Q4 2025–Q3 2026 total $300K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.
American Association for Cancer Research
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $300K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $100K | 1 |
| Q1 2023 | $100K | 1 |
| Q2 2023 | $100K | 1 |
| Q3 2023 | $100K | 1 |
| Q4 2023 | $100K | 1 |
| Q1 2024 | $100K | 1 |
| Q2 2024 | $100K | 1 |
| Q3 2024 | $100K | 1 |
| Q4 2024 | $100K | 1 |
| Q1 2025 | $100K | 1 |
| Q2 2025 | $100K | 1 |
| Q3 2025 | $100K | 1 |
| Q4 2025 | $100K | 1 |
| Q1 2026 | $100K | 1 |
| Q2 2026 | $100K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$375K · 15 reports
- Health issues$375K · 15 reports
- Medical research and clinical labs$375K · 15 reports
- Tobacco$375K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAmerican Association for Cancer Research | $1.5M | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | In-house | $100K |
| 04/17for Q1 | In-house | $100K |
| 01/16for Q4 2025 | In-house | $100K |
| 25/10/14for Q3 2025 | In-house | $100K |
| 25/07/18for Q2 2025 | In-house | $100K |
| 25/04/11for Q1 2025 | In-house | $100K |
| 25/01/21for Q2 2010 | In-house | Under $5,000 |
| 25/01/17for Q4 2024 | In-house | $100K |
| 24/10/18for Q3 2024 | In-house | $100K |
| 24/07/19for Q2 2024 | In-house | $100K |
| 24/04/23for Q1 2024 | In-house | $100K |
| 24/01/19for Q4 2023 | In-house | $100K |
| 23/10/18for Q3 2023 | In-house | $100K |
| 23/07/20for Q2 2023 | In-house | $100K |
| 23/04/10for Q1 2023 | In-house | $100K |
| 23/01/17for Q4 2022 | In-house | $100K |